Objective
The IκB kinase (IKK) is an enzyme complex that initiates the NF-κB transcription factor cascade, which is important in regulating multiple cellular responses. IKK alpha (IKKα) is directly associated with two major pro-survival pathways, PI3K/Akt and NF-κB, but its role in cell survival is not clear. Macrophages play critical roles in the pathogenesis of atherosclerosis, yet the impact of IKKα signaling on macrophage survival and atherogenesis remains unclear.
Approach and Results
Here we demonstrate that genetic IKKα deficiency, as well as pharmacologic inhibition of IKK, in mouse macrophages significantly reduces Akt S473 phosphorylation, which is accompanied by suppression of mTORC2 signaling. Moreover, IKKα null macrophages treated with lipotoxic palmitic acid exhibited early exhaustion of Akt signaling compared to WT cells. This was accompanied by a dramatic decrease in the resistance of IKKα−/− monocytes and macrophages to different pro-apoptotic stimuli compared to WT cells. In vivo, IKKα deficiency increased macrophage apoptosis in atherosclerotic lesions and decreased early atherosclerosis in both female and male LDLR−/− mice reconstituted with IKKα−/− hematopoietic cells and fed with the Western diet for 8 weeks compared to control LDLR−/− mice transplanted with WT cells.
Conclusions
Hematopoietic IKKα deficiency in mouse suppresses Akt signaling, compromising monocyte/macrophage survival and this decreases early atherosclerosis.